Product Images Acyclovir

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Acyclovir NDC 68071-2299 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PDP - 68071 2299 3

PDP - 68071 2299 3

This appears to be a product description for Acyclovir 200mg capsules sold by NuCare Pharmaceuticals, Inc. The product contains 30 capsules and is only available via prescription. It is oval, opaque, and light blue in color. The warnings on the label advise users to keep the product out of reach of children and to report side effects to the FDA. The capsules should be stored in a controlled environment at a temperature between 68-77°F. The product has a lot number of 000000 and a GTIN of 00368071229936. However, some of the text is not readable, and the information provided is limited.*

Structural Formula - acy03 0000 01

Structural Formula - acy03 0000 01

Table 1 - acy03 0000 02

Table 1 - acy03 0000 02

Table 1 presents the pharmacokinetic characteristics of Acyclovir, which is a medication used to treat herpes virus infections. The table shows the range for different parameters such as plasma protein binding and plasma elimination half-life. The average oral bioavailability ranges from 10% to 20%, with a decrease in bioavailability as the dose increases.*

Table 2 - acy03 0000 03

Table 2 - acy03 0000 03

This text provides information on the peak and trough concentrations of Acyclovir at steady state for different dosages (200mg, 400mg, and 800mg). It includes the concentration values for both peak (Coax) and trough (Cirough) levels.*

Table 3 - acy03 0000 04

Table 3 - acy03 0000 04

Table 3 shows the dosage modification for patients with different levels of renal impairment. The table gives the normal dosage alongside the adjusted dosage regimen for individuals with creatinine clearance of less than or greater than 10 mL/min/1.73 m2 or between 10-25 mL/min/1.73m2. The adjusted dosages vary based on the level of renal impairment, and the dosages range from 200mg to 800mg every 4 hours, 5 times a day, or every 12 hours, depending on the patient's condition.*

Imprint CTI 114 - acy03 0000 05

Imprint CTI 114 - acy03 0000 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.